Crossmark

4′‐Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of <scp>PKAN</scp>

Crossref DOI link: https://doi.org/10.15252/emmm.201910489

Published Online: 2019-10-29

Published Print: 2019-12

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Jeong, Suh Young https://orcid.org/0000-0002-6376-7001
Hogarth, Penelope

Placzek, Andrew

Gregory, Allison M

Fox, Rachel https://orcid.org/0000-0001-6265-2256
Zhen, Dolly

Hamada, Jeffrey

van der Zwaag, Marianne

Lambrechts, Roald

Jin, Haihong

Nilsen, Aaron

Cobb, Jared

Pham, Thao

Gray, Nora

Ralle, Martina

Duffy, Megan

Schwanemann, Leila

Rai, Puneet

Freed, Alison

Wakeman, Katrina

Woltjer, Randall L

Sibon, Ody CM https://orcid.org/0000-0002-6836-6063
Hayflick, Susan J https://orcid.org/0000-0003-2595-3943
Funding

Funding for this research was provided by:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (R21HD088833)

National Institute of Neurological Disorders and Stroke (R01NS109083)

NBIA Disorders Association

Collins Foundation

National Center for Advancing Translational Sciences (UL1TR0002369)
License Information

Version of Record valid from 2019-10-29
More Information

Publication History

Received: 2019-02-19

Accepted: 2019-08-14

Published: 2019-10-29